TG Therapeutics | TGTX - Trade Creditors

Stock Price
28.47
Daily Change
0.71 2.56%
Monthly
-6.16%
Yearly
-13.96%
Q1 Forecast
28.52

TG Therapeutics reported $61.64M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 32.25B 1.2B Jun/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Amgen USD 19.64B 1.61B Sep/2025
Ardelyx USD 18.39M 3.29M Sep/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Bayer EUR 6.38B 343M Sep/2025
Biogen USD 432M 18.9M Dec/2025
Corcept Therapeutics USD 34.45M 10.92M Sep/2025
Dynavax Technologies USD 3.95M 1.25M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
J&J USD 9.62B 161M Sep/2025
Novartis USD 4.56B 49M Sep/2025
PTC Therapeutics USD 36.62M 169.69M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025